Study: Pulmonary Hypertension in Patients With Pulmonary Fibrosis
A new literature review looks at the role of pulmonary hypertension in people with pulmonary fibrosis.
Category: Pulmonary Fibrosis
Pulmonary Fibrosis
Latest
Pulmonary Fibrosis
Latest
Pulmonary Fibrosis Awareness Month Celebrates PF Heroes
September is Pulmonary Fibrosis Awareness Month. This year the Pulmonary Fibrosis Foundation is celebrating PF Heroes who are raising awareness of the disease.
Pulmonary Fibrosis
Popular
Country Music Artist Joe Nichols Raising Awareness of IPF
Country music artist Joe Nichols is partnering with Boehringer Ingelheim Pharmaceuticals to raise awareness of idiopathic pulmonary fibrosis.
Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis: Causes, Diagnosis, and Treatment
Pulmonary fibrosis (PF) is a complex interstitial lung disease that afflicts an estimated 100,000 Americans, with 30-40,000 new cases diagnosed each year.
Read More
Pamrevlumab Reduced Lung Function Decline in IPF
According to research in The Lancet Respiratory Medicine, investigational antibody pamrevlumab reduced lung function decline and slowed disease progression in patients with idiopathic pulmonary fibrosis (IPF).
Read More
Pulmonary Fibrosis Drug Development Pipeline Launched
The PF Foundation has launched a new PF Drug Development Pipeline tool to help the pulmonary fibrosis community search for different treatment options.
Read More
Idiopathic Pulmonary Fibrosis Drugs Increase Longevity, Decrease Hospitalizations
Pulmonary fibrosis drugs pirfenidone and nintedanib appear to increase longevity and decrease hospitalizations in IPF patients.
Read More
Occupational Hazards Account for More Than One in Ten People with Range of Lung Diseases
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of...
Read More
PFF Patient Registry Research Generates 23 Studies
To date, 23 studies, including abstracts and manuscripts, have been developed or are underway using data from the Pulmonary Fibrosis Foundation Patient Registry.
Read More
Drug Reduced FVC Decline in Pulmonary Fibrosis Patients
A clinical study of patients with idiopathic pulmonary fibrosis treated with PRM-151 demonstrated the drug had a sustained benefit on 6-minute walking distance and on reducing FVC decline.
Read More
Trial to Test Therapy for Persistent Cough in Pulmonary Fibrosis
Respivant Sciences has dosed the first patient in the SCENIC trial, a Phase 2b study of RVT-1601 for the treatment of persistent cough in patients with idiopathic pulmonary fibrosis (IPF).
Read More
PF Foundation Reaffirms Caution Over Stem Cell Therapies for PF
The Pulmonary Fibrosis Foundation strongly cautions patients with PF against using stem cell treatments outside of an approved clinical trial.
Read More
Idiopathic Pulmonary Fibrosis Diagnostic Gets Medicare Coverage
Veracyte Inc has received a final Medicare local coverage determination (LCD) for the Envisia Genomic Classifier, a genomic diagnostic for idiopathic pulmonary fibrosis (IPF).
Read More
Mutation Prevents Mucus Clearance in Small Airways
Investigators have identified a connection between mucus in the small airways and pulmonary fibrosis.
Read More
New Resource for Pulmonary Fibrosis Patients
Responsum for PF is a free service that allows patients to easily access trusted, comprehensive, and understandable content for pulmonary fibrosis patients, families and caregivers.
Read More